Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

8.45
Delayed Data
As of May 26
 +0.10 / +1.20%
Today’s Change
5.50
Today|||52-Week Range
14.60
-21.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues236.9K299.4K299.4K299.4K
 
 
 
 
 
Depreciation And Amortization39.2K952.00953.00952.00
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses9.7M10.4M10.4M15.0M
 
 
 
 
 
Research And Development6.9M7.2M7.3M9.6M
 
 
 
 
 
Total Operating Expenses9.7M10.4M10.4M15.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.5M-10.1M-10.1M-14.7M
 
 
 
 
 
Other Expenses10.4K1.4K-299.000.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.3M-9.9M-10.0M-14.6M
 
 
 
 
 
Income Taxes-26.8K-8.8K-10.3K0.00
 
 
 
 
Net Income-9.3M-9.9M-10.0M-14.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.8M17.8M17.9M21.8M
 
 
 
 
 
Shares To Calculate EPS Diluted17.8M17.8M17.9M21.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.52-$0.56-$0.56-$0.67
 
 
 
 
 
EPS Diluted-$0.52-$0.56-$0.56-$0.67